Chapters
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 | Arachis oil enema | ||
 | Bisacodyl | ||
| Co-danthramer capsules | For terminally ill patients | |
| Co-danthramer suspension | For terminally ill patients | |
| Co-danthrusate capsules | For terminally ill patients | |
| Danthron | Treatment of constipation in terminally ill patients | |
| Docusate capsules | ||
| Docusate liquid | ||
| Fleet Phospho-Soda | ||
| Glycerin suppositories | ||
| Isphagula husk | ||
| Klean prep | ||
| Lactulose solution | ||
 | Linaclotide | For moderate to severe IBS-Constipation. For patients who have not responded adequately to or cannot tolerate all other suitable treatment options BUT BEFORE other agents with higher costs. | |
| Macrogol sachets e.g. Laxido | ||
| Micro-enema | ||
| Misoprostol | Specialist use only | |
| Moviprep | For radiology use | |
| Naldemedine (Rizmoic®) | ||
| Naloxegol (Moventig®) | For treating opioid-induced chronic constipation - use in line with NICE | |
| Phosphate enema | ||
| Picolax | Bowel cancer screening | |
| Plenvu® | ||
| Prucalopride | Available for use in men and women for chronic constipation. | |
| Senna syrup | ||
| Senna tablets | ||
| Sodium citrate enema |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
